chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BUD date excursion, BUD was 4-7-23 and vaccine administered 4-21-23.
Very sore throat, swollen glands, fatigue, body aches. I also received a flu shot at the time I received the shingles vaccine. I get a flu shot every year and have never had a reaction. Went to my doctor and she gave me a prescription for penicillin. She looked at my throat and said it did not look like I have strep throat.
Experienced pain that she voiced seems like muscle pain from her shoulder to her elbow; Experienced pain that she voiced seems like muscle pain from her shoulder to her elbow; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 92 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 16Mar2021 (Batch/Lot number: unknown) at the age of 92 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "left mastectomy", start date: 1994 (unspecified if ongoing), notes: left mastectomy with lymph node removal. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose1, Dosage text: injected in right arm), administration date: Feb2021, when the patient was 91 years old, for COVID-19 immunization.The following information was reported: PAIN IN EXTREMITY (non-serious), MYALGIA (non-serious) all with onset Mar2021, outcome "not recovered" and all described as "Experienced pain that she voiced seems like muscle pain from her shoulder to her elbow". The event "experienced pain that she voiced seems like muscle pain from her shoulder to her elbow" and "experienced pain that she voiced seems like muscle pain from her shoulder to her elbow" was evaluated at the physician office visit. Therapeutic measures were not taken as a result of pain in extremity, myalgia.  Additional information: She recieved the second Pfizer Covid 19 Vaccine on 16March2021. Since the vaccine in March she has experienced pain that she voiced seems like muscle pain from her shoulder to her elbow. That is the arm she recieved the vaccine in due to left mastectomy with lymph node removal. Caller asking if they symptoms are normal and how long it may last. AE Treatment: Caller says she did not treat it, it was not out of the ordinary, the part about it was the fact that it seemed to have affected muscle, and she just has it sometimes, she has severe pain in it sometimes like needles sticking in it. She says the other people she talks to about it have the same type symptoms. Caller provides no further details about the other people who had symptoms. Caller says she doesn't take shots in that arm, her left arm, so she thought since it has been so long since she had her mastectomy that it might be all right to take the shot in that arm but they tell her since they removed lymph nodes that was reason she shouldn't take shots in that arm because it didn't have anything to fight infection, so she just does what they tell her to do.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (Fever) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 037K2019) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included LISINOPRIL and VITAMINS NOS (DAILY VITAMINS) for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) for Fever, at an unspecified dose and frequency. In February 2021, PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The other health care professional (speech therapist) stated that the fever lasted for around 24 hours.
Extreme tiredness began the evening I took the vaccine. The next morning on 1/16/21 I had a severe dizziness, flu-like symptoms of nausea, fatigue, fever, lack of appetite.  Symptoms improved somewhat the next day. On 1/18/21 I still have dizziness and fatigue.
rash on both legs-around inj site rough little bumps sl fever x 1 day
Migraine; Nausea; Severe muscle spasms on right side of body; Dizziness; Weakness; Heartbeat elevated 20 bpm; Pain and swelling at injection site; Swelling at injection site; Chills; Vomiting; Loss of appetite; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 15:00 (at the age of 43-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 15:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included Polycystic Ovarian Syndrome (PCOS) and chronic inflammation. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medications included metformin (MANUFACTURER UNKNOWN), low-dose naltrexone (MANUFACTURER UNKNOWN) and estradiol (MANUFACTURER UNKNOWN), all taken for an unspecified indication from an unknown date and unknown if ongoing. On an unknown date in Apr2021 at 04:30, 12 hours after the shot, the patient experienced migraine, nausea, severe muscle spasms on right side of the body every 30 seconds, dizziness, weakness, heartbeat elevated 20 beats per minute (bpm), pain and swelling at injection site and chills. On an unknown date in Apr2021, 20 hours after the shot, the patient experienced muscle spasms right side, vomiting, chills, loss of appetite and migraine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, nausea, severe muscle spasms on right side of body, dizziness, weakness, heartbeat elevated 20 bpm, pain and swelling at injection site, chills, vomiting and loss of appetite was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
localized pain, swelling of rt thigh p/multiple vaccinations @ the site-improving spontaneously
Dizziness, vertigo, fever, malaise, nausea, headache, and vomiting.
extreme muscle & joint pain in both legs, diaphragm, shoulders, hands, h/a, t012 occurred about 2 wk p/vax & lasted about 8-9days;
Patients describes cold sweats, headaches, flu like symptoms, body aches, shakes. Fever was over 100 degrees, sore arm that is more than usual, he cannot lift it.
Started breaking out with eczema; This is a spontaneous report from a contactable consumer (patient himself). A 79-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6206; expiration date was not reported), via unspecified route of administration, in the left arm, on 10Mar2021 at 10:00 (at the age of 79-year-old), as single dose for COVID-19 immunization. The patient's medical history included diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity. The patient's concomitant medications included ongoing allopurinol (strength: 150mg) for gout from unspecified date, taken it for 2 or 3 years and also reported other unspecified concomitant products. The patient's historical vaccine included first dose of BNT162B2 (COMIRNATY, solution for injection, Lot number: EN9809; expiration date was not reported), via unspecified route of administration, in the left arm, on 19Feb2021 (at the age of 79-year-old), as single dose for COVID-19 immunization. Patient got both shots of the COVID Vaccine in mid Mar2021, and he had no side effects and was doing good. About a month later, and he has never had it, he started breaking out with eczema in at the beginning of May2021 at late afternoon. He also went to a dermatologist. Patient had an appointment on 18May2021. When asked if it had improved, was persisting, or had worsened, he states it was not serious and was breaking out in little patches here and there. The dermatologist gave him a steroid cream. No additional vaccines administered on same date of the Pfizer Suspect. Patient did not receive any prior vaccinations within 4 weeks. Patient did not receive any emergency room and physician office visit for eczema. Outcome of the event was unknown.
Pt had a syncopal event 12 hours after her flu and COVID vaccines were administered at her local pharmacy.  She has had flu and COVID vaccines in the past (previous Pfizer for COVID) but not on the same day in the past. She was able to get up and get back in bed.  Endorses some HA, neck ache, chills, and nausea, which have since resolved.
Pt complained of sore arm for 2 days after injection but said it was better after that. Then he complained that muscle soreness and sharp pains had returned to his arm around injection site had reappeared about 2 days ago however he could not pinpoint a time that the soreness returned. Referred him to physician office to get arm checked out. Pt did have a rash on arm but it was below injection site as well as on the back of his arm. Pt stated he often gotten rashes all over his body and did not contribute to the vaccination.
I had tingling and pins and needles on the left side of my face and inside my mouth on my tongue on the left side; This is a spontaneous report from a contactable other hcp. This Other-HCP (patient) reported that a 39-years-old non-pregnant female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: not reported), dose 1 via intramuscular route, in left arm on 05Feb2021 11:30 (at 39-years age) as dose 1, single for covid-19 immunisation. Medical history included covid-19. There were no concomitant medications. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date, the patient had tingling and pins and needles on the left side of her face and inside her mouth on her tongue on the left side. Patient did not received treatment for event. Since the vaccination, patient has been not tested for COVID-19. Patient was not received other medications in two weeks. The clinical outcome of event was not resolved.  Information of Lot/Batch number has been requested.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
pt exp an unspecified rxn p/flu vax;No further details known as of the date of this report
PREVNAR 13 vaccination given in left deltoid 11/21/2016. (L) arm erythema and itching, induration at site 4 cm and slightly raised. Erythema involved entire upper arm. No systemic reaction-no fever/chills/hives/difficulty breathing.
Experienced headaches and dizziness for 2 weeks after second shot and still experiencing dizziness after 4 weeks.
Bad itchiness on my face, neck and torso with rash.  No relief with Benadryl.
On 08/15/2000 the patient developed a rash over her chest, abdomen and both arms. The patient's mother described the rash as "red dots under the skin", not varicella-like. The patient had no fever and was treated with Caladryl. The patient sought unspecified medical attention. On 08/28/2000 the school nurse reported that the patient was at school feeling fine and the rash disappeared after 3 hours on 08/25/2000. On 08/30/2000 the mother reported the patient had red swollen areas on her arms with no fever, and the red area was noted to be approximately 1.5 inch in diameter. Subsequently it was reported that the patient recovered.
Fast heart beat; Tiredness; joint pain; Chills; Headache; Muscle pain; High fevers; couldnt stop sweating.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 00:00, the patient experienced fast heartbeat, tiredness, joint pain, chills, headache, muscle pain and patient was under 3 blankets for 2 days and could not stop sweating, high fevers and could not go to work on Monday. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. The clinical outcome of the events fast heart beat tiredness, joint pain, chills, headache, muscle pain and could not stop sweating, high fever was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
pt stated that became very ill when she went to bed.  she woke up in a cold sweat, had vomiting and diarrhea that lasted an entire next day.  she had headache and chills but no fever.  pt had a phone visit w PCP and they told her to stay hydrated and get bed rest.  Doctor will FU tomorrow 3/10/2021.  Pt states she is feeling better at this time.
with every dose of the vaccine caller has had muscle problems; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77-year-old female patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Apr2023 as dose 5 (booster), single (Lot number: GJ6742) at the age of 77 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (ongoing), notes: in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus.; "Hashimoto's" (ongoing), notes: Hashimoto's; "Fibromyalgia" (ongoing), notes: Fibromyalgia; "Sjogren's" (ongoing), notes: Sjogren's. The patient's family history included: "Rheumatoid arthritis" (ongoing), notes: in her late 30s. Doctor tried to figure out if it was rheumatoid arthritis or Lupus. There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Batch/lot number: EN6205, Anatomical location: Upper left arm), administration date: 02Mar2021, for Covid-19 immunization, reaction(s): "polymyalgia rheumatica", "had muscle problems", "arm irritation", "arm tenderness"; bnt162b2 (DOSE 2, SINGLE, Batch/Lot number: ER8727, Anatomical location: Upper left arm), administration date: 23Mar2021, for Covid-19 immunization, reaction(s): "arm sensitive/ had tenderness", "every muscle in body was bothering patient/ muscle problems", "leg cramps", "very tired", "Headache", "sore throat", "polymyalgia rheumatica"; bnt162b2 (DOSE 3 (BOOSTER), SINGLE, Batch/Lot number: 30135BA, Anatomical location: Upper left arm), administration date: 21Oct2021, for Covid-19 immunization, reaction(s): "with every dose of the vaccine caller has had muscle problems", "Pericarditis", "couldn't breathe"; bnt162b2;bnt162b2 omi ba.4-5 (DOSE 4 (BOOSTER), SINGLE, Batch/Lot number: GH9694, Anatomical location: Upper left arm), administration date: 21Sep2022, for Covid-19 immunization, reaction(s): "with every dose of the vaccine caller has had muscle problems". The following information was reported: MUSCLE DISORDER (non-serious) with onset 2023, outcome "unknown", described as "with every dose of the vaccine caller has had muscle problems".  Additional information: It was clarified and confirmed that caller had all of the Pfizer COVID-19 vaccines.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300337361 same patient/vaccine, different doses/event.;
Mother stated the child began fever, cold chills, uncontrollable shaking and hallucinations at 130 am on 3/19/11. Child was taken to ER where labs and x-ray were taken. Mother stated the x-ray showed PMA in left lobe. Antibiotics and breathing treatments were started. The child was sent home in care of mother (RN). Follow up visit will be Friday 3/25.
Sore arm for several months after injection. Arm tightness, tingling in arms and fingers
The LPN came to the COVID Vaccine Clinic Manager and stated that he felt like the shot that he just gave to the patient was an empty syringe.  The nurse stated that he did not verify the syringe and the dosage prior to injecting the patient..  The remaining syringes at the injection station were examined and located a syringe that did not contain any medication and was drawn up to 0.1 ml which was the same amount that the nurse had felt was in the syringe that he had injected into the patient.  The empty vials of Moderna vaccine were examined and there was no extra medication remaining in the vials.  The RN spoke to the patient and he stated that he did not have any feeling that anything was put into his arm.  Patient reports he had no questions or concerns about being administered a vaccine at this time.  Monitored the patient for 30 minutes and no concerns noted during the monitoring period.  The process was revised that only the nursing lead would get the vaccines from the nurse drawing up vaccines and the nursing lead would examine each vaccine syringe prior to giving to vaccinator.
This spontaneous report as received from a registered nurse refers to a 6 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 03-NOV-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M006112 with expiry date: 16-NOV-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705:
Extremely high blood pressure; Tightness in chest; Tightness in throat; A spontaneous report was received from a consumer who was a 77-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced extremely high blood pressure, tightness in chest, and tightness in throat.  The patient's medical history was not provided. Concomitant product use included an unspecified medication used for thyroid.   On 07 Jan at 1:30 pm, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011J20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 07 Jan 2021, less than five minutes after receiving the vaccine,  the patient experienced severe symptoms. Symptoms included, extremely high blood pressure, tightness in chest, and tightness in throat. The person in charge of monitoring reactions after the vaccine, took the patient's blood pressure and had to call an ambulance. The patient was taken to the hospital and remained there for hours. At the hospital, she was seen by her cardiologist and had unspecified laboratory and diagnostic work done. The patient was sent home on the same day and symptoms did not continue. Treatment for the events included acetylsalicylic acid and an unspecified medication that was placed under the patient's tongue.   Action taken with mRNA-1273 in response to the events was not provided.   The events, extremely high blood pressure, tightness in chest, and tightness in throat, were considered resolved on 07 Jan 2021.; Reporter's Comments: This case concerns a 77-year-old female patient who received their first of two planned doses of mRNA-1273 (Lot 011J20A), and who experienced the non-serious unlisted events of high blood pressure, tightness in chest and tightness in throat.  Based on the current available information and temporal association between the use of the product and the onset of events on the day of vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
cold; really sick; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), ILLNESS (really sick), CHILLS (chills) and MYALGIA (body aches) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced NASOPHARYNGITIS (cold), ILLNESS (really sick), CHILLS (chills) and MYALGIA (body aches). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (cold), ILLNESS (really sick), CHILLS (chills) and MYALGIA (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included ibuprofen. Concomitant medication was not reported.
Mild symptoms on date of injection included soreness and injection site approximately 1 hour to 24 hours post-injection, nausea and dizziness and flushing approximately 1 hour after injection, lasting 2 hours.  On day eight following injection, at approximately 2:00 a.m. I noticed pain in my right arm at the injection site as well as muscle stiffness and pain from right arm injection site over to scapula and neck area. My husband noted a red rash, mild, extending from the injection site approximately 5 in down my arm. He took a picture of the mild rash.
Member received Tdap in Left deltoid on 5/31/2023. Complained of arm pain june 2nd, 2023. Member also received Rocephin injection in the same route.
Sore Injection site left arm (same arm as first one) thru the armpit, swelling in left arm, tiredness & fatigue, foggy brained, extreme body aches and pain, unable to walk from weakness, nausea, excruciating headaches, irregualar heartbeat, nausea.  Reddness and swelling in arm for over 1wk.  Nausea about 10 days.
This spontaneous report as received from a female patient of unknown age consumer regarding herself. The patient's concurrent conditions, medical history, concomitant medications and drug reaction/ allergies were not reported. On an unknown date, the patient was vaccinated with as stated "an unknown "chicken-pox" vaccine"(manufacturer unknown) for prophylaxis (strength, frequency, route of administration and lot number of all suspected vaccines were not reported).   On an unknown date, the patient's body basically did not have an effective immune response to the vaccination because she said she only became "65 percent immune" to the varicella virus". The outcome of drug effect incomplete and the causality assessment with the unspecified chicken pox vaccine were unknown.